Company Filing History:
Years Active: 1996
Title: The Innovations of Stefan Brantschen
Introduction
Stefan Brantschen is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of virology, particularly in the study and isolation of hepatitis A viruses. His work has implications for vaccine development and diagnostic tools.
Latest Patents
Stefan Brantschen holds a patent for a new hepatitis A virus strain, specifically the RG-SB XA112 (CNCM I-1080). This invention relates to hepatitis A viruses that display unique immunological characteristics. The patent also covers methods for isolating these viruses and their structural components. The HAVs developed through this invention can be utilized in the production of vaccines and diagnostic compositions. Additionally, the patent includes the development of polyclonal and monoclonal antibodies directed towards the new HAVs.
Career Highlights
Brantschen is associated with the Schweiz Serum & Impfinstitut Bern, where he has been involved in groundbreaking research. His work has contributed to advancements in vaccine technology and the understanding of hepatitis A viruses.
Collaborations
One of his notable collaborators is Reinhard Glück, with whom he has worked on various projects related to virology and vaccine development.
Conclusion
Stefan Brantschen's innovative work in the field of hepatitis A virus research has the potential to significantly impact public health through improved vaccines and diagnostic methods. His contributions continue to be relevant in the ongoing fight against viral infections.